Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Saranas Early Bird Bleed Monitoring System

N.º K: K230273 · 2023-05-25

SolicitanteSaranas, Inc.
Fecha de decisión2023-05-25
Código de productoQFJ
Comité asesorCV
DecisiónSubstantially Equivalent

Resumen del dispositivo

Saranas Early Bird Bleed Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Saranas, Inc.. It received FDA 510(k) clearance on 2023-05-25 under 510(k) number K230273. The device is classified under product code QFJ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Saranas Early Bird Bleed Monitoring System?

Saranas Early Bird Bleed Monitoring System is a medical device that received FDA 510(k) clearance on 2023-05-25. The listed applicant is Saranas, Inc.. The 510(k) number is K230273.

When did Saranas Early Bird Bleed Monitoring System receive FDA 510(k) clearance?

Saranas Early Bird Bleed Monitoring System received FDA 510(k) clearance on 2023-05-25, under 510(k) number K230273.

Who is the listed applicant for Saranas Early Bird Bleed Monitoring System?

The FDA 510(k) record lists Saranas, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Saranas Early Bird Bleed Monitoring System?

The FDA product code for Saranas Early Bird Bleed Monitoring System is QFJ.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑